Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 145

    1.

    Hepatocellular injury in a patient receiving pioglitazone.

    Maeda K.

    Ann Intern Med. 2001 Aug 21;135(4):306. No abstract available. PMID: 11511159 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    [A case of drug induced liver injury related pioglitazone]

    Hisamochi A, Kumashiro R, Koga Y, Tanaka E, Ide T, Hino T, Murashima S, Ogata K, Kuwahara R, Koga H, Shishido S, Ueno T, Sata M, Eguchi T.

    Nippon Shokakibyo Gakkai Zasshi. 2003 Mar;100(3):333-6. Japanese. No abstract available. PMID: 12696176 [PubMed - indexed for MEDLINE]Related articles

    3.

    Late-onset troglitazone-induced hepatic dysfunction.

    Bell DS, Ovalle F.

    Diabetes Care. 2000 Jan;23(1):128-9. No abstract available. PMID: 10857986 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    What caused this patient's sudden liver dysfunction?

    Porterfield LM.

    RN. 2001 Mar;64(3):98. No abstract available. PMID: 11288655 [PubMed - indexed for MEDLINE]Related articles

    5.

    Pioglitazone-induced hepatic injury in a patient previously receiving troglitazone with success.

    Nagasaka S, Abe T, Kawakami A, Kusaka I, Nakamura T, Ishikawa S, Saito T, Ishibashi S.

    Diabet Med. 2002 Apr;19(4):347-8. No abstract available. PMID: 11943013 [PubMed - indexed for MEDLINE]Related articles

    6.

    Failure to develop hepatic injury from rosiglitazone in a patient with a history of troglitazone-induced hepatitis.

    Lenhard MJ, Funk WB.

    Diabetes Care. 2001 Jan;24(1):168-9. No abstract available. PMID: 11194222 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    Pioglitazone-associated fulminant hepatic failure.

    Chase MP, Yarze JC.

    Am J Gastroenterol. 2002 Feb;97(2):502-3. No abstract available. PMID: 11866308 [PubMed - indexed for MEDLINE]Related articles

    8.

    Hepatocellular injury in a patient receiving rosiglitazone. A case report.

    Al-Salman J, Arjomand H, Kemp DG, Mittal M.

    Ann Intern Med. 2000 Jan 18;132(2):121-4. Erratum in: Ann Intern Med 2000 Aug 1;133(3):237. PMID: 10644273 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    Mixed hepatocellular-cholestatic liver injury after pioglitazone therapy.

    May LD, Lefkowitch JH, Kram MT, Rubin DE.

    Ann Intern Med. 2002 Mar 19;136(6):449-52.PMID: 11900497 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    [Pioglitazone]

    Kobayashi M, Iwata M, Hiratani K.

    Nippon Rinsho. 2002 Sep;60 Suppl 9:429-37. Review. Japanese. No abstract available. PMID: 12387029 [PubMed - indexed for MEDLINE]Related articles

    11.

    Pioglitazone (Actos).

    [No authors listed]

    Med Lett Drugs Ther. 1999 Nov 19;41(1066):112. No abstract available. PMID: 10987011 [PubMed - indexed for MEDLINE]Related articles

    12.

    Severe but reversible cholestatic liver injury after pioglitazone therapy.

    Pinto AG, Cummings OW, Chalasani N.

    Ann Intern Med. 2002 Nov 19;137(10):857. No abstract available. PMID: 12435231 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    Thiazolidinedione hepatotoxicity: a class effect?

    Tolman KG.

    Int J Clin Pract Suppl. 2000 Oct;(113):29-34. Review.PMID: 11965828 [PubMed - indexed for MEDLINE]Related articles

    14.

    Hepatotoxicity with thiazolidinediones: is it a class effect?

    Scheen AJ.

    Drug Saf. 2001;24(12):873-88. Review.PMID: 11735645 [PubMed - indexed for MEDLINE]Related articles

    15.

    Severe but reversible hepatitis induced by troglitazone.

    Schiano T, Dolehide K, Hart J, Baker AL.

    Dig Dis Sci. 2000 May;45(5):1039-42. No abstract available. PMID: 10795774 [PubMed - indexed for MEDLINE]Related articles

    16.

    Diabetes drug Rezulin: take it, but take precautions.

    [No authors listed]

    Health News. 1999 May 10;5(6):7. No abstract available. PMID: 10546576 [PubMed - indexed for MEDLINE]Related articles

    17.

    Summary for patients. Liver damage in a person taking the diabetes drug pioglitazone.

    [No authors listed]

    Ann Intern Med. 2002 Mar 19;136(6):I65. No abstract available. Erratum in: Ann Intern Med 2002 May 7;136(9):711. PMID: 11900516 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    Does pioglitazone, like troglitazone, increase serum levels of lipoprotein(a) in diabetic patients?

    Nagai Y, Abe T, Nomura G.

    Diabetes Care. 2001 Feb;24(2):408-9. No abstract available. PMID: 11213903 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    Angioneurotic edema as a side effect of pioglitazone.

    Shadid S, Jensen MD.

    Diabetes Care. 2002 Feb;25(2):405. No abstract available. PMID: 11815525 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    Company played down drug's risks, report says.

    Gottlieb S.

    BMJ. 2001 Mar 24;322(7288):696. No abstract available. PMID: 11264205 [PubMed - indexed for MEDLINE]Related articlesFree article

    Display Settings:

    Format
    Items per page
    Sort by

    Send to:

    Choose Destination

    Supplemental Content

    Find related data